Advertisement

Ads Placeholder
Loading...

DexCom, Inc.

DXCM•NASDAQ
Healthcare
Medical - Devices
$62.22
$-0.15(-0.24%)
U.S. Market opens in 20h 27m

DexCom, Inc. (DXCM) Stock Overview

Explore DexCom, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap24.3B
P/E Ratio28.77
EPS (TTM)$2.09
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$54.04
3 Months$77.63
1 Year Target$63.96

DXCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DexCom, Inc. (DXCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $63.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.77 and a market capitalization of 24.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.24%
5-Day Change
-5.60%
1-Month Change
-14.86%
3-Month Change
-6.49%
6-Month Change
-7.20%
Year-to-Date (YTD) Change
-6.49%
1-Year Change
0.68%
3-Year Change
-46.01%
5-Year Change
-32.40%
All-Time (Max) Change
2016.33%

Contact Information

https://www.dexcom.com
858 200 0200
6340 Sequence Drive, San Diego, CA, 92121

Company Facts

102,000 Employees
IPO DateApr 14, 2005
CountryUS
Actively Trading

Frequently Asked Questions